JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB56772

Anti-MTHFD2 antibody [4G7-2G3]

Be the first to review this product! 리뷰 제출

|

(13 제품이 사용된 논문 )

Mouse Monoclonal MTHFD2 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 13 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human MTHFD2.
4 이미지
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)

MTHFD2 antibody (ab56772) used in immunohistochemistry at 3μg/ml on formalin fixed and paraffin embedded human lymphoma tissue.

Flow Cytometry - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)

Overlay histogram showing HepG2 cells stained with ab56772 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab56772, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
This image was generated using the ascites version of the product.

Western blot - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)
  • WB

Unknown

Western blot - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)

MTHFD2 antibody (ab56772) at 1μg/lane + HepG2 cell lysate at 25μg/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-MTHFD2 antibody [4G7-2G3] (ab56772)

Predicted band size: 38 kDa,42 kDa,43 kDa

Observed band size: 42 kDa

false

Western blot - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)
  • WB

Lab

Western blot - Anti-MTHFD2 antibody [4G7-2G3] (AB56772)

Lanes 1-4 : Merged signal (red and green). Green - ab56772 observed at 36 kDa. Red - loading control ab52901 observed at kDa.

ab56772 Anti-MTHFD2 antibody was shown to specifically react with MTHFD2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266383 (knockout cell lysate ab258528) was used. Wild-type and MTHFD2 knockout samples were subjected to SDS-PAGE. ab56772 and Anti-beta Tubulin [EP1331Y] - Microtubule Marker (ab52901) were incubated at room temperature for 2.5 hours at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-MTHFD2 antibody [4G7-2G3] (ab56772) at 1/500 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

MTHFD2 knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human MTHFD2 knockout HEK-293T cell line (<a href='/ko/products/cell-lines/human-mthfd2-knockout-hek-293t-cell-line-ab266383'>ab266383</a>)

Lane 3:

HepG2 cell lysate at 20 µg

Lane 4:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution

Predicted band size: 38 kDa

Observed band size: 36 kDa

false

주요 정보

Host species

Mouse

Clonality

Monoclonal

Clone number

4G7-2G3

Isotype

IgG2a

Light chain 타입

kappa

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, IHC-P, WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human MTHFD2.

P13995

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/ko/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

제품 세부 정보

This product was changed from ascites to tissue culture supernatant on 24/1/19. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

특성 및 보관 정보

제형
Liquid
Purity
Tissue culture supernatant
Purification 관련 사항
Purified from TCS.
보관 버퍼
pH: 7.4
배송 시 보관 조건
Blue Ice
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

MTHFD2 also known as methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 is an enzyme with a mass of approximately 36 kDa. It catalyzes the conversion of methylenetetrahydrofolate to methenyltetrahydrofolate using NADP+ as a cofactor. MTHFD2 is a mitochondrial protein and is highly expressed in embryonic tissues and various cancers while showing low expression in normal adult tissues. This differential expression makes it an interesting target for cancer research.
Biological function summary

Methylenetetrahydrofolate dehydrogenase plays an important role in folate metabolism contributing to the one-carbon metabolic pathway. MTHFD2 is part of the tetrahydrofolate (THF) complex critical for DNA synthesis and repair. The enzyme supports the production of nucleotides and amino acids by providing necessary one-carbon units linking it to rapid cellular proliferation as seen in cancerous cells.

Pathways

MTHFD2 is key in connecting the folate-mediated one-carbon metabolic network to the central metabolism. It is involved in the metabolic pathways that synthesize purines and thymidylate. In these networks MTHFD2 interacts with proteins such as SHMT2 (serine hydroxymethyltransferase 2) facilitating serine to glycine conversion which is important for the provision of one-carbon donors for methylation reactions.

The upregulation of MTHFD2 strongly associates with various cancers including breast and colorectal cancers. The involvement of MTHFD2 in these cancers indicates its potential as a biomarker and therapeutic target. Through cancer-related pathways MTHFD2 shows a connection to enzymes such as ALDH1L2 (aldehyde dehydrogenase 1 family member L2) which also participates in folate metabolism and influences cancer progression.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Although its dehydrogenase activity is NAD-specific, it can also utilize NADP at a reduced efficiency.
See full target information MTHFD2

대체 명칭 보기

NMDMC, MTHFD2

제품이 사용된 논문 (13)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Nature communications 15:9529 PubMed39532843

2024

Nuclear localization of MTHFD2 is required for correct mitosis progression.

Applications

Unspecified application

Species

Unspecified reactive species

Natalia Pardo-Lorente,Anestis Gkanogiannis,Luca Cozzuto,Antoni Gañez Zapater,Lorena Espinar,Ritobrata Ghose,Jacqueline Severino,Laura García-López,Rabia Gül Aydin,Laura Martin,Maria Victoria Neguembor,Evangelia Darai,Maria Pia Cosma,Laura Batlle-Morera,Julia Ponomarenko,Sara Sdelci

Molecular oncology 18:2179-2195 PubMed38533616

2024

The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation.

Applications

Unspecified application

Species

Unspecified reactive species

Petra Marttila,Nadilly Bonagas,Christina Chalkiadaki,Hannah Stigsdotter,Korbinian Schelzig,Jianyu Shen,Crystal M Farhat,Amber Hondema,Julian Albers,Elisée Wiita,Azita Rasti,Ulrika Warpman Berglund,Ana Slipicevic,Oliver Mortusewicz,Thomas Helleday

Nature metabolism 5:642-659 PubMed37012496

2023

Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Alanna C Green,Petra Marttila,Nicole Kiweler,Christina Chalkiadaki,Elisée Wiita,Victoria Cookson,Antoine Lesur,Kim Eiden,François Bernardin,Karl S A Vallin,Sanjay Borhade,Maeve Long,Elahe Kamali Ghahe,Julio J Jiménez-Alonso,Ann-Sofie Jemth,Olga Loseva,Oliver Mortusewicz,Marianne Meyers,Elodie Viry,Annika I Johansson,Ondřej Hodek,Evert Homan,Nadilly Bonagas,Louise Ramos,Lars Sandberg,Morten Frödin,Etienne Moussay,Ana Slipicevic,Elisabeth Letellier,Jérôme Paggetti,Claus Storgaard Sørensen,Thomas Helleday,Martin Henriksson,Johannes Meiser

Journal of translational medicine 20:423 PubMed36138435

2022

Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Dianke Li,Huansha Yu,Junjie Hu,Shaoling Li,Yilv Yan,Shuangyi Li,Liangdong Sun,Gening Jiang,Likun Hou,Lele Zhang,Peng Zhang

Acta neuropathologica communications 9:16 PubMed33468252

2021

Glioma cells require one-carbon metabolism to survive glutamine starvation.

Applications

Unspecified application

Species

Unspecified reactive species

Kazuhiro Tanaka,Takashi Sasayama,Hiroaki Nagashima,Yasuhiro Irino,Masatomo Takahashi,Yoshihiro Izumi,Takiko Uno,Naoko Satoh,Akane Kitta,Katsusuke Kyotani,Yuichi Fujita,Mitsuru Hashiguchi,Tomoaki Nakai,Masaaki Kohta,Yoichi Uozumi,Masakazu Shinohara,Kohkichi Hosoda,Takeshi Bamba,Eiji Kohmura

Molecular biology reports 47:7089-7096 PubMed32880830

2020

Detection and characterisation of novel alternative splicing variants of the mitochondrial folate enzyme MTHFD2.

Applications

Unspecified application

Species

Unspecified reactive species

Vicky Nicolaidou,Christos Papaneophytou,Costas Koufaris

Oncogene 38:6211-6225 PubMed31289360

2019

MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Nathanael H Green,Daniel L Galvan,Shawn S Badal,Benny H Chang,Valerie S LeBleu,Jianyin Long,Eric Jonasch,Farhad R Danesh

Oncogene 38:2464-2481 PubMed30532069

2018

Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.

Applications

Unspecified application

Species

Unspecified reactive species

Tatsunori Nishimura,Asuka Nakata,Xiaoxi Chen,Kurumi Nishi,Makiko Meguro-Horike,Soichiro Sasaki,Kenji Kita,Shin-Ichi Horike,Kaori Saitoh,Keiko Kato,Kaori Igarashi,Takahiko Murayama,Susumu Kohno,Chiaki Takahashi,Naofumi Mukaida,Seiji Yano,Tomoyoshi Soga,Arinobu Tojo,Noriko Gotoh

Cancer research 77:937-948 PubMed27899380

2016

Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor.

Applications

Unspecified application

Species

Unspecified reactive species

Robert Gustafsson,Ann-Sofie Jemth,Nina M S Gustafsson,Katarina Färnegårdh,Olga Loseva,Elisée Wiita,Nadilly Bonagas,Leif Dahllund,Sabin Llona-Minguez,Maria Häggblad,Martin Henriksson,Yasmin Andersson,Evert Homan,Thomas Helleday,Pål Stenmark

The Journal of experimental medicine 213:1285-306 PubMed27325891

2016

Targeting MTHFD2 in acute myeloid leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Yana Pikman,Alexandre Puissant,Gabriela Alexe,Andrew Furman,Liying M Chen,Stacey M Frumm,Linda Ross,Nina Fenouille,Christopher F Bassil,Caroline A Lewis,Azucena Ramos,Joshua Gould,Richard M Stone,Daniel J DeAngelo,Ilene Galinsky,Clary B Clish,Andrew L Kung,Michael T Hemann,Matthew G Vander Heiden,Versha Banerji,Kimberly Stegmaier
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com